Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 8/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.40 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 5/20 | 0.35 |
| ▸ | RAB9A | P51151 | 5/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 5/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16612601 | 0.78 | DDAH1 (0.50) | NPC1RAB9AL3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL16612797 | 0.78 | HCRTR2 (0.40) | HCRTR2NPC1RAB9AL3MBTL1TP53 | |
| SCHEMBL16613039 | 0.78 | MEN1 (0.46) | HCRTR2HCRTR1NPC1RAB9AL3MBTL1 | |
| SCHEMBL16612643 | 0.77 | HCRTR1 (0.39) | HCRTR2HCRTR1L3MBTL1 | |
| SCHEMBL16613032 | 0.75 | HCRTR2 (0.44) | HCRTR2 | |
| SCHEMBL16612999 | 0.73 | HCRTR2 (0.53) | LTA4HKCNH2HCRTR2HCRTR1NPC1 | |
| SCHEMBL16612782 | 0.72 | HCRTR2 (0.39) | HCRTR2HCRTR1 | |
| SCHEMBL16612739 | 0.71 | TDP1 (0.54) | NPC1L3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL9403508 | 0.70 | KMT2A (0.44) | LTA4HNPC1RAB9AL3MBTL1TP53 | |
| SCHEMBL16612710 | 0.70 | KDM4E (0.49) | HCRTR2NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2675801-B1 | NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2015-04-08 | — | — | EP | disclosed |